Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (370)
  2. Journal Article (365)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (803)
  2. Department of Medicine (803)
  3. Gastrointestinal Oncology Service (803)
  4. Solid Tumor Oncology Division (803)
  5. Epidemiology and Biostatistics (184)
  6. Surgery (173)

More Groups

People
  1. Ghassan Abou-Alfa (160)
  2. Kenneth Yu (123)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (97)
  6. William Jarnagin (88)

More People

Years
  1. 2025 (50)
  2. 2024 (76)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (296)
  2. Annals of Oncology (51)
  3. Cancer (28)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (312)
  2. Oxford University Press (75)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (43)
  6. American Association for Cancer Research (40)

More Publishers

Results (803)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant nab-paclitaxel + gemcitabine in resected pancreatic ductal adenocarcinoma: Results from a randomized, open-label, phase III trial
    Journal Article

    Tempero, M. A.; Pelzer, U.; O'Reilly, E. M.; Winter, J.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; Lopez, C. D.; Bekaii-Saab, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Journal Article

    Ecker, B. L.; Tao, A. J.; Janssen, Q. P.; Walch, H. S.; Court, C. M.; Balachandran, V. P.; Crane, C. H.; D'Angelica, M. I.; Drebin, J. A.; Kingham, T. P.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
    Journal Article

    Singh, R. R.; Klein, A. P.; Sharma, N. R.; O'Reilly, E. M.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Association of inflammatory biomarkers with survival among patients with stage III colon cancer
    Journal Article

    Cheng, E.; Shi, Q.; Shields, A. F.; Nixon, A. B.; Shergill, A. P.; Ma, C.; Guthrie, K. A.; Couture, F.; Kuebler, P.; Kumar, P.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Physical activity in stage III colon cancer: CALGB/SWOG 80702 (Alliance)
    Journal Article

    Brown, J. C.; Ma, C.; Shi, Q.; Fuchs, C. S.; Meyer, J.; Niedzwiecki, D.; Zemla, T.; Couture, F.; Kuebler, P.; Kumar, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Potential mediators of oxaliplatin-induced peripheral neuropathy from adjuvant therapy in stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702
    Journal Article

    Lee, S.; Ma, C.; Shi, Q.; Kumar, P.; Couture, F.; Kuebler, P.; Krishnamurthi, S.; Lewis, D.; Tan, B.; Goldberg, R. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX plus radiotherapy in patients with borderline resectable pancreatic cancer-The A021501 Trial - In reply
    Correspondence

    Katz, M. H. G.; Herman, J. M.; O'Reilly, E. M.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192
    Meeting Abstract

    Reiss, K. A.; Hong, S. C.; Kasi, A.; O'Reilly, E. M.; Maithel, S. K.; Yao, X.; Hamilton, S. R.; Boursi, B.; Pishvaian, M. J.; Klempner, S. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) and biomarkers in daNIS-2, a phase III study comparing NIS793 plus nab-paclitaxel/gemcitabine (NG) vs placebo plus NG in first-line (1L) metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Meeting Abstract

    Wainberg, Z. A.; Macarulla, T.; Golan, T.; Ikeda, M.; Milella, M.; Taieb, J.; Wang, L.; Gyambibi, N.; López, E. M.; Bento Pereira da Silva, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation
    Meeting Abstract

    Yu, K. H.; Weekes, C. D.; Chen, Y. B. A.; Glazier, J. A.; Glazier, A.; Dahi, P.; Giralt, S.; O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save